Gram-negative sepsis in neonates may be rising since start of GBS prophylaxis.
Kaye
D
D
D000667:Ampicillin / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000009:adverse effects*; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D010406:Penicillins / Q000627:therapeutic use; D018805:Sepsis / Q000453:epidemiology* / Q000382:microbiology*; D013290:Streptococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D013292:Streptococcus agalactiae
D010406:Penicillins; D000667:Ampicillin